Objective: Although storage alters red blood cells, several recent, randomized trials found no differences in clinical outcomes between patients transfused with red blood cells stored for shorter versus longer periods of time. The objective of this study was to see whether storage impairs the in vivo ability of erythrocytes to traverse the microcirculation and deliver oxygen at the tissue level.
Methods: A subset of subjects from a clinical trial of cardiac surgery patients randomized to receive transfusions of red blood cells stored 10 days or !21 days were assessed for thenar eminence and cerebral tissue hemoglobin oxygen saturation (S t O 2 ) via the use of near-infrared spectroscopy and sublingual microvascular blood flow via side-stream darkfield videomicroscopy.
Results: Among 55 subjects, there was little change in the primary endpoint (thenar eminence S t O 2 from before to after transfusion of one unit) and the change was similar in the 2 groups: þ1.7% (95% confidence interval, À0.3, 3.8) for shorter-storage and þ0.8% (95% confidence interval, À1.1, 2.9) for longerstorage; P ¼ .61). Similarly, no significant differences were observed for cerebral S t O 2 or sublingual microvascular blood flow. These parameters also were not different from preoperatively to 1 day postoperatively, reflecting the absence of a cumulative effect of all red blood cell units transfused during this period.
Conclusions: There were no differences in thenar eminence or cerebral S t O 2 , or sublingual microcirculatory blood flow, in cardiac surgery patients transfused with red blood cells stored 10 days or !21 days. These results are consistent with the clinical outcomes in the parent study, which also did not differ, indicating that storage may not impair oxygen delivery by red blood cells in this setting. (J Thorac Cardiovasc Surg 2017;153:610-9)
Change in thenar eminence tissue hemoglobin oxygen saturation Pre-to Posttransfusion of red blood cells stored 10 days or !21 days.
Central Message
Red cell storage did not impair tissue oxygenation or microcirculation in cardiac surgery patients, consistent with lack of difference in clinical outcomes.
Perspective
The impact of red cell storage on clinical outcomes has been controversial, but recent randomized trials have demonstrated no differences between patients receiving red cells stored for shorter versus longer periods. In a subset of cardiac surgery patients in one of these trials, we found no differences in tissue oxygenation and microcirculatory blood flow, consistent with the clinical outcomes.
See Editorial Commentary page 620.
The changes occurring in red blood cells (RBCs) under conventional storage conditions have been well described 1 and have led to the hypothesis that they might impair RBC function in the transfusion recipient. 2 A number of observational, usually retrospective, studies comparing clinical outcomes in patients receiving RBCs stored for different 3, 4 including studies that were conducted in patients undergoing cardiac surgery. 5, 6 The Red Cell Storage Duration Study (RECESS), the parent trial for the study reported here, compared clinical outcomes among patients undergoing complex cardiac surgery who were randomized to receive RBC stored 10 days or !21 days. 7 Other randomized clinical trials addressed the clinical impact of RBC storage duration in neonates 8 and critically ill adults, 9 but none of these 3 trials demonstrated any differences in clinical outcome measures. A large, randomized study in children with severe anemia measured lactate clearance as well as clinical endpoints and also found no differences between the patients receiving RBCs stored 1 to 10 days versus 25 to 35 days. 10 Relatively few studies in humans have addressed the effect of RBC storage at the tissue level via the use of physiologic endpoints such as tissue oxygen saturation of hemoglobin [11] [12] [13] [14] or microcirculatory blood flow, 15, 16 and none of them were designed to correlate such physiologic measurements with clinical outcomes. The primary objective of the National Institutes of HealthÀfunded Red Cell Storage Duration Study Ancillary Physiologic Study (RECAP) was to determine whether the storage duration of RBCs affects tissue oxygen saturation of hemoglobin, as measured by near-infrared spectroscopy (NIRS), and microcirculatory blood flow, as measured using sidestream darkfield (SDF) videomicroscopy, in patients who had undergone complex cardiac surgery, and whether these measurements would be consistent with the clinical outcomes observed in the parent trial. The intention of this study was to examine events at the tissue level that might provide insight into the apparent paradox between the well-documented changes that occur to RBCs during storage and the lack of measurable clinical impact.
MATERIALS AND METHODS Oversight
RECAP (NCT01274390) was a multicenter, prospective, clinical trial that enrolled patients at 4 sites belonging to the Transfusion Medicine and Hemostasis Clinical Trials Network. RECAP was conducted as an ancillary trial to a parent study carried out by the network, RECESS (NCT00991341) and was funded independently by National Heart, Lung, and Blood Institute/National Institutes of Health with no commercial support. The 4 enrolling sites for RECAP were Duke University, the Johns Hopkins University, Massachusetts General Hospital, and the University of Pittsburgh. The Data Statistical Coordinating Center was New England Research Institutes. The study was designed by the authors and approved by the institutional review boards at each participating hospital. Study subjects provided written informed consent. The same data and safety monitoring board oversaw the parent study and RECAP. This study received the following institutional review board approvals: Duke University Medical Center, 12 
Study Patients
The patients participating in this study were a subset of subjects who were enrolled in the RECESS study at 4 of the participating sites. Patients were eligible for the parent study 11 if they were scheduled for complex cardiac surgery via median sternotomy and were likely to require RBC transfusion as determined by a Transfusion Risk Understanding Score Tool (TRUST) of 3 or greater. 17 Additional eligibility criteria for RECAP were age at least 18 years and scheduled coronary artery bypass grafting, valve repair or replacement, or a combination. Patients were approached and consented for RECAP at the same time they were consented for the parent study. Randomization could not be done any earlier than the day before surgery. Subjects who could not be randomized were no longer eligible for RECAP.
Study Design and Treatment Protocols
For the parent study, subjects were assigned randomly, in a 1:1 ratio, to receive units of RBCs stored for 10 days or !21 days for all transfusions from the time of randomization through the earliest of day 28, death, or discharge from the hospital. Randomization was balanced by site 18 with the use of a centralized computer system. All units were prestorage leukoreduced RBCs collected in standard, licensed additive solution systems and were not irradiated or washed. The expiration dates of the units were not obscured, but the central laboratory (Shapiro Laboratory, Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Boston, Mass), which analyzed the primary raw electronic data files for the oxygenation and microcirculatory flow measurements, was blinded to study arm assignment. Microcirculatory blood flow. The sublingual microcirculation was visualized with SDF videomicroscopy (Microscan; Microvision Medical, Inc, Amsterdam, The Netherlands) as previously described. 19 Multiple videoclips of up to a minute each were captured at the 4 time points defined herein. The videoclips were stored on a laptop computer and uploaded to the central laboratory by use of the same proprietary file transfer software and cloud storage. Details of the processing and analysis of the videoscans are described in Appendix E1. The microcirculatory parameters reported in this study were proportion of perfused small vessels (PPV) and the change in PPV (DPPV); microcirculatory flow index for small vessels (MFI and DMFI); perfused small vessel density (PVD and DPVD); and total small vessel density (TVD and DTVD). For the perfusion parameters (PPV, DPPV, PVD, DPVD), any vessel segment with a flow score greater than or equal to 2 (sluggish or continuous flow) was considered perfused. Following the guidelines of a consensus report, we estimated MFI as the average over 4 quadrants of the field of view of the most prominent flow in the vessels that occupied each quadrant. 20 Timing of measurements. Measurements were made at 4 time points: within 6 hours before surgery; within 2 hours before a postoperative RBC transfusion that took place in the intensive care unit (ICU) at any point within the 24 hours after surgery; within 2 hours after that postoperative RBC transfusion; and 24 AE 4 hours after the end of surgery. If measurements could not be obtained before and after the first postoperative transfusion, or if the first transfusion included more than 1 unit, the measurements could be made before and after a subsequent RBC transfusion, as long as that single unit of RBC was transfused in the ICU within 24 hours after the conclusion of surgery. For each patient, the first RBC transfusion for which measurements could be obtained was considered the ''index'' transfusion. The measurements within 2 hours before and after the index transfusion were intended to capture transient changes in tissue oxygenation, whereas the preoperative and 24-hour postoperative measurements would reflect the cumulative impact of the transfusion of multiple units of RBCs.
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Statistical Analysis
All analyses were conducted by a statistician (S.G.) at the Data and Statistical Coordinating Center (New England Research Institutes). Data on the changes in physiologic parameters were compared between treatment groups via analysis of covariance, with adjustment for the pretransfusion value. Binary and categorical variables were compared between treatment groups via the Fisher exact test, and effect sizes were calculated with the Cramer phi statistic. Continuous variables were compared with KruskalWallis tests, and effect sizes were calculated as the absolute difference in means divided by the pooled standard deviation.
The primary endpoint was the change in the peripheral S t O 2 from within 2 hours before transfusion to within 2 hours after a postoperative RBC transfusion in the ICU (DS t O 2 ). The protocol-defined secondary endpoints were the change in the cerebral oxygen saturation of hemoglobin and the changes in 4 parameters of microcirculatory blood flow (DMFI, DPPV, DPVD, and DTVD) over this same time period. Other secondary outcomes were the changes in all 6 of these measurements from the period 6 hours before surgery to 24 AE 4 hours after surgery. No imputation was done for missing data points.
Subjects were considered to be analyzable for pre-to posttransfusion changes in a RECAP outcome if they had been randomized successfully in RECESS, underwent a cardiac surgical procedure, had an index transfusion in the ICU, and had valid data for the outcome being analyzed. Similarly, subjects were considered evaluable for changes from presurgery to 1 day postsurgery if they were randomized in RECESS, had surgery, received at least one RBC unit during this time period, and had valid data for the outcome. As specified in the protocol, an intention-to-treat analysis was conducted with data from all participants who met the criteria for evaluation listed previously, regardless of what storage-duration RBCs actually were received. Secondary per-protocol analyses were carried out in a similar way, including only subjects who received RBCs in accordance with their assigned treatment group from randomization through 1 day after surgery.
RESULTS
Patients and Treatment Assignments
Between January 2011 and January 2014, 130 subjects in the parent trial also consented to participate in RECAP ( Figure 1 ). Of these, 7 were ineligible for RECAP: 2 had a planned surgical procedure that did not meet the inclusion criteria for RECAP, and 5 could not be randomized in RECESS because the blood bank could not meet the crossmatch request with units of RBC for both storage durations. There were 6 eligible RECAP subjects (3 in each treatment arm) who did not undergo surgery. Of the remaining subjects, 59 were randomized to the arm receiving RBC stored 10 days, and 58 to the arm receiving RBC stored !21 days. Of these, 23 in the 10 days arm and 32 in the !21 days arm received at least 1 unit of RBC within 24 AE 4 hours of leaving the operating room (OR) for which measurements could be obtained (index transfusions).
The baseline characteristics of patients in the 2 arms of the study were similar (Table 1) , including the frequency of significant comorbidities and the distribution of ABO blood groups. The baseline Multiple Organ Dysfunction Score 21 was lower in the !21 days arm (P .01) but the difference was less than 1.0 point and both values were very low. Serum creatinine also was lower in this group, but the levels were mostly within the reference range and the differences between the groups were small ( 0.5 mg/dL). The characteristics of the surgical procedures also were comparable between the 2 groups ( Table 2 ). The baseline characteristics of the RECAP subjects were very similar to those for the parent study, RECESS, as a whole 7 (Table E1) .
Transfusions
The storage duration of the RBC units transfused to the RECAP patients intraoperatively and within 24 hours of leaving the OR is shown in Figure 2 and Table 3 . The mean (AEstandard deviation) storage duration for RBCs transfused to subjects assigned to receive units stored 10 days was 8.2 AE 4.7 days; for units transfused to subjects in the !21 day arm, the mean (AEstandard deviation) storage duration was 27.9 AE 7.4 d. The median storage times (quartile 1, quartile 3) were 7 days (6,9) and 28 days (23, 34) respectively. Adherence to the study arm assignment was high, with 92% of units transfused to subjects in the 10 day arm and 93% of units transfused to subjects in the !21 day arm meeting study requirements. Of the subjects in the shorter storage arm of the study, 87% received only units stored 10 days, whereas 93% of subjects in the longer storage-arm received only units stored !21 days.
The mean number of RBCs transfused up to and including the index transfusion, for subjects with an index transfusion, was 3.6 AE 2.8 units (median 3.0 units) in the 10 day arm and 2.9 AE 2.3 units (median 2.5 units) in the !21 day arm (P ¼ .30). The mean number of RBCs transfused through 24 hours postoperatively was greater than 4 units per subject for both groups, and a similar proportion of subjects received more than 6 units of RBCs (Table 3 ). The volumes of other blood components transfused to the patients in both arms also were similar.
Physiologic Measurements
As shown in Table E2 , the subjects in the 2 arms of the study were comparable with respect to several key clinical characteristics within 2 hours preceding the transfusion of a single unit of RBC in the ICU postoperatively: systolic and diastolic blood pressure, heart rate, blood O 2 saturation, and level of respiratory and inotropic support. Figure 3 and Table 4 show the results of the S t O 2 measurements at the thenar eminence as determined by NIRS within 2 hours before and after transfusion of this postoperative RBC transfusion, time points that might be expected to detect real, albeit transient, changes in tissue oxygenation. Before the postoperative RBC transfusion, the 2 groups of patients also showed similar levels of thenar eminence S t O 2 with means of approximately 78%. After transfusion of one unit of RBC, the S t O 2 levels were again comparable between the 2 groups, with very little change compared to the pretransfusion levels. The change in S t O 2 from pre-to posttransfusion was only an increase of 1.7% (95% confidence interval [CI], À0.3, 3.8) in the 10 days group and 0.8% (95% CI, À1.1, 2.7) in the !21 day group; the difference was not statistically significant. Based on the number of subjects and the observed standard deviation for change in thenar oxygen saturation, this comparison had 80% power to detect a 0.8% difference between treatment groups, a difference not likely to be clinically significant. As shown in Figure 3 , C, the changes in S t O 2 tended to be slightly greater for patients with lower pretransfusion values than patients with greater pretransfusion values; however, the slopes were very similar between treatment groups (interaction P value .92).
Comparable results were observed for measurements of cerebral S t O 2 levels by NIRS (Table 4 ). The pretransfusion cerebral S t O 2 levels were comparable between the 2 groups, although lower than the readings at the thenar eminence (around 62%) and showed a statistically significant but small increase after transfusion in both groups. The increases in the mean cerebral S t O 2 from pre-to posttransfusion were only 2.6% (95% CI, 1.3-3.9) in the 10 day group and 1.6% (95% CI, 0.5-2.7) in the !21 day group and did not differ from one another.
The videomicroscopy images of the sublingual microcirculation were analyzed for 4 parameters characterizing blood flow. See Video 1 for an example. There were no clinically important changes in response to RBC transfusion, nor any apparent difference in that response between the 2 study groups, but the number of observations was too small to be statistically meaningful.
Similar comparisons were made for the changes in these parameters from within 6 hours before the start of surgery to 24 AE 4 hours after surgery to assess the possible cumulative effect of multiple units of RBCs. The subjects in both arms received on average approximately 4 units of RBCs in this time period (Table 3) , which represents approximately one third of their RBC mass. There was a slightly greater change in the thenar eminence DS t O 2 (3%-4%) than was observed before and after the transfusion of a single unit, but there was not a significant difference between the 2 arms. Similarly, the modest changes in the other parameters of tissue oxygenation and microcirculatory blood flow were not different between the subjects receiving shorter-or longer-storage RBCs. The treatment group comparisons of physiologic changes also were not statistically significant in the per-protocol analyses (all P values > .35).
DISCUSSION
This study used Food and Drug Administrationapproved, minimally invasive techniques for monitoring tissue hemoglobin oxygen saturation (NIRS) and blood flow through the microcirculation (SDF videomicroscopy). NIRS captures the level of hemoglobin oxygen saturation in small vessels and capillaries. It has been used in multiple clinical situations to gauge effectiveness of resuscitation efforts, vascular flow sufficiency, and transfusion efficacy in neonates, 22 patients who are septic, 23 patients in critical care, 24 patients undergoing surgery, 25 and outpatients. 26 SDF videomicroscopy has been used to interrogate the microcirculation of critically ill patients, especially those with sepsis, 27 as well as to assess the effect of RBC transfusion in the setting of sepsis, 23, 28 cardiac surgery, 29 and trauma. 30 Although RBC transfusion was associated with improved tissue S t O 2 levels in many of these studies, this was not the case in all of them. For example, when RBCs stored>21 days were transfused to trauma patients, tissue oxygen saturation decreased. 11 The primary finding of this study is that there were no differences in tissue oxygen saturation or microvascular blood flow between patients who received RBC stored 10 days versus !21 days. This finding is consistent with the results of the parent trial, RECESS, which also found no differences in clinical outcomes including the primary outcome measure, change in the Multiple Organ Dysfunction Score through 7 days, or any of the other secondary outcomes. 12 Although the RECAP subset was not large enough to compare these clinical outcomes independently with any statistical power, the similarity between the baseline patient characteristics and surgical characteristics of the RECAP study population and the entire RECESS cohort, as well as their comparable clinical outcomes (Table E1) suggests that storage of RBCs for 21 days or more does not affect their function in patients undergoing cardiac surgery, as measured by these clinical and physiologic endpoints. The results of 3 other large, randomized clinical trials in vulnerable populations, adult 9 and neonatal ICU patients, 8 and children with severe anemia 10 likewise found no differences in clinical outcomes among subjects receiving RBC stored for shorter versus longer periods of time. Thus, the absence of measurable physiologic differences between patients receiving shorter-versus longer-storage RBC is reflected in the absence of observable clinical effects as well. The apparently equivalent clinical and physiologic effects of RBCs stored for greater or lesser amounts of time have been observed consistently in randomized trials OR, Operating room; RBC, red blood cell; SD, standard deviation; Q1, first quartile; Q3, third quartile; FFP, fresh-frozen plasma. *P values for continuous variables are from a Kruskal-Wallis nonparametric test; P values for categorical variables are from the Fisher exact test. yEffect sizes for binary and categorical variables were calculated by use of Cramer phi statistic and were calculated as the absolute difference in means divided by the pooled standard deviation for continuous variables. z1 U h 1 U apheresis platelets or 6 U whole blood platelets. despite the well-described changes that occur in banked erythrocytes. This consistency makes it less likely that the clinical endpoints used to date have been too insensitive to detect subtle defects in RBC function at the tissue level. The second finding is that independent of storage duration, RBC transfusion had very little effect on tissue oxygen saturation or microcirculatory flow in the subjects in this study. One possible reason is that banked RBCs, no matter how briefly they have been stored, fail to deliver oxygen to tissues. Another possibility is that even the techniques deployed in this study to assess these parameters were not sensitive to the effects of RBC transfusion. Among patients with very low hemoglobin levels or existing hypoxemia, however, RBC transfusion has been shown to improve tissue oxygenation as measured by NIRS [11] [12] [13] [14] and microcirculatory blood flow as visualized by SDF imaging. 15, 16 A third possible explanation for the absence of significant changes after RBC transfusion in this study is that most of these patients were neither oxygendeprived nor supply limited. This observation raises the question of the utility of these postoperative RBC transfusions. In a medically resource-rich setting, RBCs often are transfused to prevent tissue ischemia, despite the fact that the minimum hemoglobin concentration required to achieve this goal has not been defined in most clinical situations and may not be the best marker to identify which patients are likely to benefit from transfusion. Indeed, it can be argued that patients who are in bed and not exercising require relatively modest arterial oxygen content. Consistent with this supposition, studies comparing restrictive and liberal RBC transfusion strategies generally have found that there is no clinical detriment to maintaining patients at the lower of the 2 hemoglobin levels tested, 31 including in the setting of cardiac surgery. 32, 33 One key strength of the study is its link to a large parent study that was powered for clinical endpoints and complemented the physiologic measurements reported here. In addition, RECAP was performed at 4 different facilities, enhancing the generalizability of the findings, and randomization was balanced by site, thereby minimizing the effects of differences in patient populations and clinical practices among participating hospitals. Adherence to the study intervention was excellent, with greater than 90% of RBC units transfused to the study subjects having been stored for the assigned period of time, and achieved a wide separation in the median RBC storage times (21 days) between the 2 arms.
There are several limitations, however, to the study. Enrollment was lower than anticipated and additional sites could not be added because of the limitation in the number of devices available for the study. In addition, fewer patients received postoperative RBC transfusions than originally projected based on historical data, which may be attributable to the implementation of patient blood-management programs 34 and the gradual adoption of more conservative transfusion practices based on clinical trials data. 32, 33 Missing data points also highlight the logistical challenges of obtaining some of these timed measurements in unstable patients in the ICU setting, especially for the videomicroscopy, which requires active intervention.
CONCLUSIONS
The use of noninvasive technology to assess tissue oxygen saturation and microcirculatory blood flow in the RECAP cohort of patients has enabled the measurement of physiologic correlates to the clinical outcomes observed in the parent study, RECESS. The physiologic measurements are consistent with the clinical endpoints; both show that outcomes are not different among cardiac surgery patients in the ICU who receive RBC stored for 10 days versus !21 days.
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APPENDIX E1. MATERIALS AND METHODS Tissue Hemoglobin Oxygen Saturation: Data Analysis
Raw data were uploaded to a cloud-based server and synchronized to a secure server at the central processing facility. The data files for tissue hemoglobin oxygen saturation (S t O 2 ) of the thenar eminence and cerebrum were parsed for absolute time and value data entries and converted to a common file format for analysis. Time data embedded in the S t O 2 datastreams were correlated with data that were recorded directly on Case Report Forms which indicated the time points defined in the Materials and Methods section of the main text. Using a custom software application written in Matlab (Mathworks, Natick, Mass), S t O 2 data were plotted as a function of time. Color-coded vertical marks delineated the times that the sensors were applied or removed, the 4 time points described previously, all recorded transfusion start and stop times, and the time the patient entered the intensive care unit. An analyst visually inspected the data plots for stability and selected a region of the plot for each measurement that was stable and within the time point window using a running average single spot measurement. The 150-sample average was taken over a period of 2.5 minutes before to 2.5 minutes after the spot to be measured. For time point A, the spot measurement was selected during a stable period in the signal within 6 hours before the incision and at least 2.5 minutes after the start of data recording and at least 2.5 minutes before entering the OR. For time point B, the spot measurement was selected during a stable period in the signal within 2 hours before the index transfusion AND at least 2.5 minutes before the start of the index transfusion. For time point C, the spot measurement was selected during a stable period in the signal within 2 hours after the index transfusion AND at least 2.5 minutes after the end of the index transfusion. For time point D, the spot measurement was selected during a stable period in the signal most proximal to 24 hours after arrival to the intensive care unit AND at least 2.5 minutes after the beginning of time point D. The software then computed and recorded an average S t O 2 value for that region of the plot.
Microcirculatory Blood Flow: Data Analysis
The Microscan video files were preprocessed to enhance contrast, edited to 5 seconds' duration, and evaluated for image quality using the method described. E1 Video files with unacceptable quality were excluded from further analysis. Video clips were sorted by quality score and up to 3 clips were selected at each of the 4 time points. Selected video files were assigned a random identification number before further analysis via AVA 3.1 software (Microvision Medical BV, Amsterdam, The Netherlands). Vessel centerlines and lumen boundaries were drawn by the use of semiautomated or manual tools in AVA. All of the microcirculatory parameters reported in this study were derived from analyses of small vessels (defined as having lumen diameters below 20 mm) because capillaries and postcapillary venules of this size are the primary sites of oxygen diffusion between blood and tissue. Blood flow in vessel segments was evaluated in a semiquantitative fashion using a scale of 0 to 3 (0: no flow, 1: intermittent flow, 2: sluggish flow, 3: continuous flow). Microcirculatory parameters were then derived from the measured small vessel total length and the perfused length. 
